Xpert Xpress SARS-CoV-2 Test

News Releases

Month Year

Month Year

Feb 14, 2023

Cepheid Receives Emergency Use Authorization from FDA for Xpert® Mpox
Dec 8, 2022

Cepheid's Multi-Target Test Design Enables Detection of Influenza Variants
Nov 16, 2022

Cepheid Introduces Xpert GBS LB XC
Nov 15, 2022

Cepheid Launches Multiplex Vaginal Panel (MVP) to Support More Accurate Women's Health Diagnosis in U.S.
Nov 7, 2022

Cepheid Receives CE Mark for Xpert® Xpress GBS
Jun 27, 2022

Cepheid and BioGX Announce Collaboration to Develop Monkeypox PCR Test for the GeneXpert® System
May 19, 2022

Cepheid Receives CE Mark for Xpert® Xpress CoV-2 plus
May 12, 2022

Cepheid Receives Emergency Use Authorization for Xpert® Xpress CoV-2 plus
Jan 25, 2022

Cepheid Receives Health Canada License for Xpert Xpress CoV-2/Flu/RSV plus

New "plus" version of test adds a 3rd gene target to enhance detection of future SARS-CoV-2 variants
Dec 1, 2021

Cepheid COVID Tests Expected to Detect Omicron Variant

PCRplus Tests Include Multi-Gene Targets

Show per page

Back to Top